Global primary cells market expected to generate around USD 13 billion by 2024, at a CAGR of around 5.5% between 2018 and 2024. Skin is vulnerable to a wide variety of toxins and microbes as it is the largest and most exposed organ. Prolonged exposure of skin to toxins results in various kinds of skin disorders.
Primary Cells Market
The report covers a forecast and an analysis of the primary cells market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the primary cells market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the primary cells market on a global level.
In order to give the users of this report a comprehensive view of the primary cells market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the primary cells market by segmenting the market based on origin, type, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.
By origin, the primary cells market includes hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart, skeletal and muscle cells, and other primary cells. By type, this market includes human primary cells and animal primary cells. Based on end-user, this global market includes life science research companies and research institutes. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Germany, Italy, France, UK, China, Japan, India, and Brazil.
The report also includes the detailed profiles of various market players, such as include Thermo Fisher Scientific, Merck KGaA, Lonza, Cell Biologics, PromoCell, ZenBio, STEMCELL Technologies, AllCells, American Type Culture Collection, and Axol Biosciences, among others.
This report segments the global primary cells market into:
Global Primary Cells Market: By Product
Global Primary Cells Market: By Type
Global Primary Cells Market: By End-User
Global Primary Cells Market: By Region
Cells are building blocks of living organisms. The technique by which the performance of cells can be studied independently of the whole entity is known as cell culture. The culture cells from an animal or plant are taken and grown under favorable and artificially controlled conditions. Majorly, there are three types of cell culture procedures—primary cell culture, secondary cell culture, and cell line. Primary cells are extracted from tissues and treated under culture conditions for growth. Sub-culture of primary cells results into the secondary culture. The cell line is defined as a cell culture established from a single cell that has a constant genetic composition.
Cancer is one of the leading causes of death worldwide. In 2018, an estimated 9.6 million deaths occurred due to cancer. Globally, around 70% of deaths from cancer occur in lower- and middle-income countries. Additionally, advantages of primary human cells over cell lines, the demand for monoclonal antibodies, increased pharmaceutical outsourcing, partnerships, collaborations, and acquisitions, and rapid expansion witnessed across biotechnology and biopharmaceutical industries are anticipated to drive the primary cells market expansion globally in the upcoming years. However, the high cost of advanced primary cells and concerns pertaining to contamination related to primary cell culture might limit the primary cells market in the future. Nevertheless, the progressive biomedical research using primary cells in 3D culture is likely to open new growth avenues in this global market in the future.
The primary cells market is classified market based on origin, type, and end-user. By origin, the primary cells market includes hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart, skeletal and muscle cells, and other primary cells. The demand for liver cells is likely to grow in the upcoming years, due to their use in a wide range of applications across various pharmacological and toxicological studies. By type, this market includes human primary cells and animal primary cells. Based on end-user, this global market includes life science research companies and research institutes.
By region, North America is projected to lead the primary cells market globally. The rising occurrences of cancer and the expansion of pharmaceutical and biotechnology industries in the region are the major factors driving the growth of the primary cells market in North America. The Asia Pacific primary cells market is expected to register the highest CAGR in the forecast timeframe, due to a large number of cancer patients and the introduction of awareness programs, conferences, and funding activities.
Few of the key players in primary cells market include Thermo Fisher Scientific, Merck KGaA, Lonza, Cell Biologics, PromoCell, ZenBio, STEMCELL Technologies, AllCells, American Type Culture Collection, and Axol Biosciences, among others.